Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 9/2012

01-09-2012 | Review

Bevacizumab in the Treatment of Ovarian Cancer

Authors: Florian Heitz, Philipp Harter, Jana Barinoff, Bianca Beutel, Paevi Kannisto, Jacek P. Grabowski, Julia Heitz, Christian Kurzeder, Andreas du Bois

Published in: Advances in Therapy | Issue 9/2012

Login to get access
Metadata
Title
Bevacizumab in the Treatment of Ovarian Cancer
Authors
Florian Heitz
Philipp Harter
Jana Barinoff
Bianca Beutel
Paevi Kannisto
Jacek P. Grabowski
Julia Heitz
Christian Kurzeder
Andreas du Bois
Publication date
01-09-2012
Publisher
Springer Healthcare Communications
Published in
Advances in Therapy / Issue 9/2012
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-012-0041-9

Other articles of this Issue 9/2012

Advances in Therapy 9/2012 Go to the issue

Review

Effects of Thiazolidinediones on Polycystic Ovary Syndrome: a Meta-analysis of Randomized Placebo-Controlled Trials

Review

Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma

Original Research

SWAAT Study: Extracorporeal Shock Wave Therapy and Arginine Supplementation and Other Nutraceuticals for Insertional Achilles Tendinopathy

Review

Effects on Lipid Profile of Dipeptidyl Peptidase 4 Inhibitors, Pioglitazone, Acarbose, and Sulfonylureas: Meta-analysis of Placebo-Controlled Trials

Original Research

Pseudobulbar Affect: Burden of Illness in the USA

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits